Results 251 to 260 of about 79,824 (366)

Atopy patch test

open access: yesIndian Journal of Dermatology, Venereology and Leprology, 2019
Abhishek De   +3 more
openaire   +2 more sources

The severity of the first occurrence of bronchiolitis increased the risk of developing asthma symptoms

open access: yesActa Paediatrica, Volume 114, Issue 6, Page 1283-1290, June 2025.
Abstract Aim The relationship between bronchiolitis and asthma is complex. We assessed whether patients admitted to a paediatric intensive care unit (PICU) with bronchiolitis had a greater risk of developing asthma than patients admitted to a paediatric ward.
Cedric Agossah   +5 more
wiley   +1 more source

Algorithms in Allergy: Organ-Specific Allergen Challenges for the Phenotyping of Chronic Respiratory Diseases. [PDF]

open access: yesAllergy
Sanchez-Torralvo D   +5 more
europepmc   +1 more source

Bullous Eruption with Cholestasis in Pregnancy

open access: yes
JEADV Clinical Practice, Volume 4, Issue 2, Page 627-629, June 2025.
Sara Al Janahi, Yusra S. Al Ali
wiley   +1 more source

A case scenario study on adherence to GINA recommendations by primary care physicians in an area of Southern Italy: the "Progetto Padre 2.0". [PDF]

open access: yesBMC Prim Care
Maniscalco M   +9 more
europepmc   +1 more source

Modulation of the atopy patch test reaction by topical corticosteroids and tar [PDF]

open access: bronze, 2000
Elisabeth G. Langeveld-Wildschut   +5 more
openalex   +1 more source

Cutaneous Side Effects of PD‐1 Inhibitors: A Single‐Center Retrospective Study

open access: yesInternational Journal of Dermatology, Volume 64, Issue 6, Page 1066-1078, June 2025.
ABSTRACT Background The introduction of immune checkpoint inhibitors (ICIs) opened a new era in cancer immunotherapy. In particular, PD‐1 inhibitors have shown remarkable efficacy in various cancers, most notably melanoma. However, the widespread use of immune checkpoint inhibitors comes with the challenge of immune‐related adverse events (irAEs), with
Melánia Pozsgai   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy